Quest Diagnostics reports Q1 adjusted EPS $2.04, consensus $1.85

Reports Q1 revenue $2.37B, consensus $2.29B. “In the first quarter, we delivered nearly 6% base business revenue growth, continuing the strong momentum of recent quarters. We also grew total revenues for the first time since the height of the pandemic nearly three years ago,” said Jim Davis, Chairman, CEO and President. “Our strong commercial focus on physicians and hospitals combined with our broad health plan access enabled us to take advantage of sustained high rates of healthcare utilization and drive new customer growth. Our investments within advanced diagnostics also enabled double digit growth within multiple key clinical areas, including brain health, women’s health and advanced cardiometabolic health.”